These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10589608)

  • 1. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit.
    Lowson SM; Hassan HM; Rich GF
    Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitric oxide gas on platelets during open heart operations.
    Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H
    Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.
    Suzuki Y; Malekan R; Hanson CW; Niewiarowski S; Sun L; Rao AK; Edmunds LH
    J Thorac Cardiovasc Surg; 1999 May; 117(5):987-93. PubMed ID: 10220694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and neutrophil distributions in pump oxygenator circuits. III. Influence of nitric oxide gas infusion.
    Sly MK; Prager MD; Li J; Harris FB; Shastri P; Bhujle R; Chao R; Kulkarni PV; Constantinescu A; Jessen ME; Eberhart RC
    ASAIO J; 1996; 42(5):M494-9. PubMed ID: 8944929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide added to the sweep gas of the oxygenator during cardiopulmonary bypass in infants: A pilot randomized controlled trial.
    Niebler RA; Chiang-Ching H; Daley K; Janecke R; Jobe SM; Mitchell ME; Varner C; Woods K; Scott JP
    Artif Organs; 2021 Jan; 45(1):22-28. PubMed ID: 32737900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exogenous nitric oxide during cardiopulmonary bypass on lung postperfusion histology.
    Palatianos GM; Paziouros K; Vassili MI; Stratigi P; Kaklamanis IL; Prapas S; Panagiotou MS; Iliopoulou E; Mardaki S; Melissari EN
    ASAIO J; 2005; 51(4):398-403. PubMed ID: 16156306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiopulmonary bypass and inhaled nitric oxide on platelets in children with congenital heart defects.
    Breuer J; Leube G; Mayer P; Gebhardt S; Sieverding L; Häberle L; Heinemann M; Apitz J
    Eur J Pediatr; 1998 Mar; 157(3):194-201. PubMed ID: 9537485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
    Jestice HK; Humphreys JE; English TA; Hoggarth CE; Wells FC
    Eur J Cardiothorac Surg; 1990; 4(1):40-4. PubMed ID: 2106334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study.
    Mazzeffi M; Lund L; Wallace K; Herrera AV; Tanaka K; Odonkor P; Strauss E; Rock P; Fiskum G
    Perfusion; 2016 Sep; 31(6):508-15. PubMed ID: 26916901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
    Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
    J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
    Bernabei A; Gikakis N; Kowalska MA; Niewiarowski S; Edmunds LH
    Ann Thorac Surg; 1995 Jan; 59(1):149-53. PubMed ID: 7529485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient adhesion of platelets in pump-oxygenator systems: influence of SMA and nitric oxide treatments.
    Li J; Sly MK; Chao R; Constantinescu A; Kulkarni PV; Wians FH; Jessen ME; Eberhart RC
    J Biomater Sci Polym Ed; 1999; 10(2):235-46. PubMed ID: 10091933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
    Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
    Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emboli from an extraluminal blood flow hollow fiber oxygenator with and without an arterial filter during cardiopulmonary bypass in a pig model.
    Dewanjee MK; Wu SM; Kapadvanjwala M; De D; Dewanjee S; Gonzalez L; Novak S; Hsu LC; Perryman RA; Duncan RC; Serafini AN; Sfakianakis GN; Horton AF
    ASAIO J; 1996; 42(6):1010-8. PubMed ID: 8959277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
    Ask A; Holt D; Smith L
    J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.